Clinical Trial Update: Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating liposomal cytarabine with high-dose methotrexate for central nervous system metastases from breast cancer; the study is completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Carcinomatosis

Drugs mentioned

• Liposomal cytarabine (cytarabine liposome)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Washington | Conditions: Central Nervous System Metastases, Leptomeningeal Metastases | Phase 2 | Status: COMPLETED | Results posted: 2017-07-07